Jeuken J - Search Results

1

RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations.

Jeuken J, van den Broecke C, Gijsen S, Boots-Sprenger S, Wesseling P. Jeuken J, et al. Acta Neuropathol. 2007 Aug;114(2):121-33. doi: 10.1007/s00401-007-0239-0. Epub 2007 Jun 23. Acta Neuropathol. 2007. PMID: 17588166

2

Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.

Jeuken J, Sijben A, Alenda C, Rijntjes J, Dekkers M, Boots-Sprenger S, McLendon R, Wesseling P. Jeuken J, et al. Brain Pathol. 2009 Oct;19(4):661-71. doi: 10.1111/j.1750-3639.2009.00320.x. Brain Pathol. 2009. PMID: 19744038 Free PMC article.

3

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P. Jeuken J, et al. J Mol Diagn. 2006 Sep;8(4):433-43. doi: 10.2353/jmoldx.2006.060012. J Mol Diagn. 2006. PMID: 16931583 Free PMC article.

4

Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization.

van Dijk M, Sprenger S, Rombout P, Marres H, Kaanders J, Jeuken J, Ruiter D. van Dijk M, et al. Among authors: jeuken j. Genes Chromosomes Cancer. 2003 Feb;36(2):151-8. doi: 10.1002/gcc.10156. Genes Chromosomes Cancer. 2003. PMID: 12508243

5

Molecular analysis as a tool in the differential diagnosis of VHL disease-related tumors.

Gijtenbeek J, Jacobs B, Boots-Sprenger S, Bonne A, Lenders J, Küsters B, Wesseling P, Jeuken J. Gijtenbeek J, et al. Among authors: jeuken j. Diagn Mol Pathol. 2005 Jun;14(2):115-20. doi: 10.1097/01.pas.0000155022.42944.73. Diagn Mol Pathol. 2005. PMID: 15905696

6

Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.

Claes A, Wesseling P, Jeuken J, Maass C, Heerschap A, Leenders WP. Claes A, et al. Among authors: jeuken j. Mol Cancer Ther. 2008 Jan;7(1):71-8. doi: 10.1158/1535-7163.MCT-07-0552. Epub 2008 Jan 9. Mol Cancer Ther. 2008. PMID: 18187807

7

Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.

Gilhuis HJ, Anderl KL, Boerman RH, Jeuken JM, James CD, Raffel C, Scheithauer BW, Jenkins RB. Gilhuis HJ, et al. Among authors: jeuken jm. Clin Neurol Neurosurg. 2000 Dec;102(4):203-209. doi: 10.1016/s0303-8467(00)00112-8. Clin Neurol Neurosurg. 2000. PMID: 11154805 Review.

8

Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.

Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, Sprenger S, Sweep F, Kiss R, Salmon I. Branle F, et al. Among authors: jeuken j. Cancer. 2002 Aug 1;95(3):641-55. doi: 10.1002/cncr.10710. Cancer. 2002. PMID: 12209758

9

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

Hiddingh L, Tannous BA, Teng J, Tops B, Jeuken J, Hulleman E, Boots-Sprenger SH, Vandertop WP, Noske DP, Kaspers GJ, Wesseling P, Wurdinger T. Hiddingh L, et al. Among authors: jeuken j. Oncotarget. 2014 Jan 30;5(2):363-74. doi: 10.18632/oncotarget.1620. Oncotarget. 2014. PMID: 24495907 Free PMC article.

10

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.

Hiddingh L, Raktoe RS, Jeuken J, Hulleman E, Noske DP, Kaspers GJ, Vandertop WP, Wesseling P, Wurdinger T. Hiddingh L, et al. Among authors: jeuken j. Sci Rep. 2014 Jun 11;4:5260. doi: 10.1038/srep05260. Sci Rep. 2014. PMID: 24919120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results